Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cellsFarnaz Hajizadeh, Farhad Jadidi‐Niaragh, Maryam Esmaily et al.|Life Sciences|2019Cited by 108
Blockage of immune checkpoint molecules increases T‐cell priming potential of dendritic cell vaccineHadi Hassannia, Farhad Jadidi‐Niaragh, Gholamabas Sabz et al.|Immunology|2019Cited by 102
E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventionsSeyed Mohammad Hosseini, Farhad Jadidi‐Niaragh, Isobel Okoye et al.|Clinica Chimica Acta|2019Cited by 70
Nanomedicine for improvement of dendritic cell-based cancer immunotherapyVida Hashemi, Farhad Jadidi‐Niaragh, Shohreh Farhadi et al.|International Immunopharmacology|2020Cited by 44
Retraction notice to “Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression” [Int. J. Biol. Macromol. 149 (2020) 487–500]Ali Masjedi, Farhad Jadidi‐Niaragh, Armin Ahmadi et al.|International Journal of Biological Macromolecules|2025Cited by 0